NCT07453394 2026-03-06
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
Clinical Trials
11 trialsNCT00072787 2024-09-03
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Taiho Oncology, Inc.
Phase 1/2 Completed
NCT02983045 2023-03-13
PIVOT-02
Nektar Therapeutics
Phase 1/2 Completed
NCT05173142 2022-03-08
HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors
Hutchmed
Phase 1/2 Unknown
NCT00064259 2021-02-17
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
National Cancer Institute (NCI)
Phase 1/2 Terminated
NCT00565370 2020-01-18
Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP
Asan Medical Center
Phase 1/2 Completed
NCT01783951 2018-07-19
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
Capital Medical University
Phase 1/2 Completed
NCT00719550 2013-12-05
AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
Amgen
Phase 1/2 Completed
NCT01611506 2013-01-09
Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer
Centre Hospitalier Universitaire Vaudois
Phase 1/2 Terminated
NCT01348009 2012-03-13
Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer
Genta Incorporated
Phase 1/2 Unknown
NCT00320515 2009-09-28
Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer
Eli Lilly and Company
Phase 1/2 Completed